|
ISRCTN
|
ISRCTN09442466
|
|
ClinicalTrials.gov identifier
|
|
|
Public title
|
Getting clinical evidence into practice for the management and prevention of stroke
|
|
Scientific title
|
|
|
Acronym
|
N/A
|
|
Serial number at source
|
RCHA225
|
|
Study hypothesis
|
Evaluation of the development and implementation of evidence-based guidelines for two key important clinical areas (TIAs and AF) in primary care.
The implementation of evidence-based guidelines on the treatment and prevention of TIAs and AF in Bradford will produce direct patient benefit. The guidelines will lead to improved quality and consistency of clinical care as well as appropriate and efficient use of local health services. The results of the evaluation will be used to inform purchasers and providers of health care about effective and practical strategies for implementing effective health care to prevent stroke. The study will provide the NHS and PCTs with a practical model for implementation as well as adding to the knowledge base of the Cochrane Collaboration.
|
|
Lay summary
|
|
|
Ethics approval
|
Not provided at time of registration
|
|
Study design
|
Randomised controlled trial
|
|
Countries of recruitment
|
United Kingdom
|
|
Disease/condition/study domain
|
Cerebrovascular disease; Transient Ischaemic Attack (TIA)
|
|
Participants - inclusion criteria
|
Patients from 3 primary care trusts
|
|
Participants - exclusion criteria
|
Does not match inclusion criteria
|
|
Anticipated start date
|
09/01/2001
|
|
Anticipated end date
|
03/01/2004
|
|
Status of trial
|
Completed |
|
Patient information material
|
|
|
Target number of participants
|
Not provided at time of registration
|
|
Interventions
|
Not provided at time of registration
|
|
Primary outcome measure(s)
|
Number and appropriateness of referrals to TIA and anticoagulant clinics. These will be measured from patient information recorded at the referral clinics.
|
|
Secondary outcome measure(s)
|
Changes in risk factors (smoking status, BMI, blood pressure) and interventions (proportion of patients taking antiplatelet agents, anticoagulants, anti-hypertensives and statins) recorded in primary care records. These will be estimated from a review of general practice records 6 months after referral.
|
|
Sources of funding
|
NHS Executive Northern and Yorkshire (UK)
|
|
Trial website
|
|
|
Publications
|
2007 results in http://www.ncbi.nlm.nih.gov/pubmed/17301206
|
|
Contact name
|
Dr
John
Wright
|
|
Address
|
Bradford Hospitals NHS Trust
Bradford Royal Infirmary
Duckworth Lane
|
|
City/town
|
Bradford
|
|
Zip/Postcode
|
BD9 6RJ
|
|
Country
|
United Kingdom
|
|
Tel
|
+44 (0)1274 364 279
|
|
Fax
|
+44 (0)1274 364 409
|
|
Email
|
|
|
Sponsor
|
NHS R&D Regional Programme Register - Department of Health (UK)
|
|
Address
|
The Department of Health
Richmond House
79 Whitehall
|
|
City/town
|
London
|
|
Zip/Postcode
|
SW1A 2NL
|
|
Country
|
United Kingdom
|
|
Tel
|
+44 (0)20 7307 2622
|
|
Fax
|
+44 (0)20 7307 2623
|
|
Email
|
dhmail@doh.gsi.org.uk
|
|
Sponsor website:
|
http://www.doh.gov.uk
|
|
Date applied
|
23/01/2004
|
|
Last edited
|
18/01/2010
|
|
Date ISRCTN assigned
|
23/01/2004
|
